Form 4: National Health Investors Director James R. Jobe Reports Transactions
SEC Form 4 Filing
Director James R. Jobe reports transactions in National Health Investors Inc. stock, including the acquisition of stock options.
Summary
- James R. Jobe, a director of National Health Investors Inc. (NHI), filed a Form 4 with the SEC.
- The report details changes in beneficial ownership of NHI securities.
- On March 3, 2025, Jobe acquired 10,000 stock options with an exercise price of $73.34, exercisable from March 3, 2025, to March 3, 2030.
- Jobe also reported jointly held common stock and common stock held in an IRA SEP.
- Additionally, Jobe holds 25,000 stock options from February 25, 2021, with an exercise price of $69.2, exercisable until February 25, 2026.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, common for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Date of existing stock options grant. |
| 03/03/2025 | Date of the reported transaction (acquisition of stock options). |
| 03/03/2025 | Start date for exercisability of new stock options. |
| 03/03/2030 | Expiration date for new stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.